Olmesartan medoxomil/amlodipine fixed dose combination versus olmesartan medoxomil alone and amlodipine alone in patients with previously untreated stage I or II essential hypertension

Trial Profile

Olmesartan medoxomil/amlodipine fixed dose combination versus olmesartan medoxomil alone and amlodipine alone in patients with previously untreated stage I or II essential hypertension

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2013

At a glance

  • Drugs Olmesartan medoxomil/amlodipine (Primary) ; Amlodipine; Olmesartan medoxomil
  • Indications Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 11 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top